The Latest in Hematology Times

Gene expression signature reveals high-grade GCB DLBCL

March 2, 2019

Lymphoma & Plasma Cell Disorders

Priority review granted to lenalidomide for FL, MZL

March 2, 2019

Gene therapy in hemophilia is just version 1.0

March 1, 2019

Myeloma therapies raise cardiovascular risks

March 1, 2019

Think duration, not dose, when managing bleeding with non–factor replacements

March 1, 2019

Bleeding Disorders

Barriers to CAR T use in the spotlight at first European meeting

February 28, 2019

CLL, GVHD may raise risk for skin cancer after allo-HCT

February 28, 2019

Selinexor hits FDA stumbling block

February 26, 2019

Emicizumab performs well in surgical setting

February 25, 2019

Bleeding Disorders

Subcutaneous FVIIa marzeptacog alfa reduced bleeding days

February 25, 2019

Bleeding Disorders

Midostaurin maintenance may reduce relapse risk in FLT3-ITD+ AML

February 25, 2019

Padua variant factor IX gene shines in AMT-061

February 25, 2019

AHA: Consider obesity as CVD risk factor in children

February 25, 2019

Pediatrics

ZUMA-1 update: Axi-cel responses persist at 2 years

February 24, 2019

Dual-targeted CAR T shows ‘clinical signal’ in NHL

February 24, 2019